Is there a difference in regional read [18F]flutemetamol amyloid patterns between end-of-life subjects and those with amnestic mild cognitive impairment?
- DOI
- 10.1007/s00259-019-04282-y
- Published
- 2019-03-13
- Container
- European Journal of Nuclear Medicine and Molecular Imaging
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s00259-019-04282-y,
title = {Is there a difference in regional read [18F]flutemetamol amyloid patterns between end-of-life subjects and those with amnestic mild cognitive impairment?},
author = {Gill Farrar and José Luis Molinuevo and Michelle Zanette},
year = {2019},
journal = {European Journal of Nuclear Medicine and Molecular Imaging},
doi = {10.1007/s00259-019-04282-y},
url = {https://doi.org/10.1007/s00259-019-04282-y}
}RIS
TY - JOUR TI - Is there a difference in regional read [18F]flutemetamol amyloid patterns between end-of-life subjects and those with amnestic mild cognitive impairment? AU - Gill Farrar AU - José Luis Molinuevo AU - Michelle Zanette PY - 2019 JO - European Journal of Nuclear Medicine and Molecular Imaging DO - 10.1007/s00259-019-04282-y UR - https://doi.org/10.1007/s00259-019-04282-y ER -
APA
Farrar, G., Molinuevo, J. L., & Zanette, M. (2019). Is there a difference in regional read [18F]flutemetamol amyloid patterns between end-of-life subjects and those with amnestic mild cognitive impairment?. European Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.1007/s00259-019-04282-y
Source records
- crossref · retrieved 2026-09-25T06:45:15.852Z